# RS BioTherapeutics, Inc. — Form C-AR (Regulation Crowdfunding)

RS BioTherapeutics, Inc. of Cumberland, MD filed a Form C-AR (Regulation Crowdfunding) with the SEC on 2025-05-02.

## Offering

- Filed: 2025-05-02
- Form: C-AR
- Accession: 0001665160-25-000955

## Issuer

- CIK: 0001932193
- Website: http://rsbiotherapeutics.com
- Legal status: Corporation
- Organized in: DE
- Incorporated: 2021-02-08
- Address: 157 Baltimore St. Suite 140, Cumberland, MD, 21502
- Employees: 5

## Financials (as filed)

- Total assets (most recent): $41K
- Cash (most recent): $14K
- Short-term debt: $590K
- Long-term debt: $189K

## People (6)

| Name | Role | Location |
| --- | --- | --- |
| Curtis Rhine | CFO | Cumberland, MD |
| Dustin Freas | Board Director | Hunt Valley, MD |
| Dean Hart | CEO | Cumberland, MD |
| Dean Hart | Chief Executive Officer | Cumberland, MD |
| Justin Molignoni | Chairman of the Board | Cumberland, MD |
| Curtis R Rhine | Chief Financial Officer | Cumberland, MD |

## Reg CF filing history (4)

| Filed | Form | Target | Max |
| --- | --- | --- | --- |
| [2024-09-06](https://search.stillhousedata.com/formc/0001665160-24-001291) | C-U | $10K | $1.2M |
| [2024-05-22](https://search.stillhousedata.com/formc/0001665160-24-000900) | C/A | $10K | $1.2M |
| [2024-04-29](https://search.stillhousedata.com/formc/0001665160-24-000649) | C | $10K | $1.2M |

## More

- [CIK 1932193 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1932193&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formc/0001665160-25-000955.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.